Article
Clinical Implications of Genetic Mutations in Myelodysplastic Syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Mar 2017
Kennedy James A, Ebert Benjamin L
Abstract excerpt
Myelodysplastic syndrome (MDS) is clonal disorder characterized by ineffective hematopoiesis and a tendency to evolve into acute myeloid leukemia (AML). Genetic studies have enabled the identification of a set of recurrently mutated genes central to the pathogenesis of MDS, which can be organized into a limited number of cellular processes, including RNA splicing, epigenetic and traditional transcriptional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
